In the control group , only GAD-7 was significantly reduced ( from 8.89 5.06 to 6.74 4.80 , P = 0.003 ) after 8 weeks therapy compared to baseline ( P < 0.05 ) while other parameters remained unchanged ( all P > 0.05 ) .